RehabCo

RehabCo Health Systems

As of August 8, 2008 , we are pleased to announce the launch of the FDA approved OmniBody Scan, an infrared thermal imaging camera that will be able to detect patterns of abnormality within the human body. In conjunction with existing technologies, the OmniBody Scan will be able to identify problems early enough for prevention and treatment. The OmniBody Scan is available for purchase and resale through the RehabCo division of American HealthChoice.

According to Pat McGlashan, President of RehabCo, “Our initial focus will be the worldwide problem of breast cancer. The dilemma that all women have is that having X-rays to detect breast cancer may cause breast cancer. The OmniBody Scan is a non-invasive tool that will have no harmful side effects. And, the earlier that breast cancer is detected equates to a much higher chance of survival, especially with Inflammatory Breast Cancer (IBC). ”

The OmniBody Scan is manufactured specifically for American HealthChoice by a respected infrared imaging manufacturer with many years of successful experience in this field. Efforts have begun to solicit resellers to penetrate the USA market with both the OmniBody Scan and our adjunct support system of providing high quality “interpretations” of the infrared images.

According to Pat McGlashan, “This is the product that we wanted from the beginning. It adheres to the highest 'gold' standards of thermography, is easy to use and offers a very high level of technology and image quality. This is a great market for RehabCo to enter and, while it took longer than anticipated, we have great expectations for this product.

Five years ago, the U.S. Preventive Services Task Force, an independent panel of experts in primary care and prevention, examined data from numerous clinical trials and estimated that screening mammography every one or two years in women in their 40s resulted in a 15 percent decrease in breast cancer mortality after 14 years of follow-up. But, analyses also made note of the potential harms of screening, including radiation exposure, procedure-associated pain, false-positive results, over-diagnosis and potentially unnecessary treatment.

Interested resellers ahould contact Pat McGlashan at patm@rehabco.com